Somnigroup International Inc. (SGI) Down 5.8% — Should I Stop the Bleeding?

  • SGI fell 5.84% to $62.40 from $66.27 the previous trading day
  • Weiss Ratings assigns C+ (Hold)
  • Market cap is $13.94B with a dividend yield of 1.00%

Somnigroup International Inc. (SGI) came under heavy selling this Tuesday, closing at $62.40 on the NYSE, a $3.87 decline from the prior session's $66.27. The drop extends a long retreat for the mattress and bedding company. SGI now sits roughly 36.7% below its 52-week high of $98.56, a level reached on February 12, 2026. A third of the stock's value has evaporated in under nine months, which tells investors how far expectations have come down since early in the year.

Volume reached 3,491,283 shares, about 14% above the 90-day average of 3,060,784. That is a meaningful step up from normal turnover, though it falls short of the panic-level activity that sometimes follows an earnings disappointment.


Why Somnigroup International Inc. Price is Moving Lower

The decline traces directly to Somnigroup's Q3 report, released on November 9, which missed on both lines and came with a guidance cut. Adjusted EPS of $1.04 fell short of the $1.06 consensus. Revenue of $2.351 billion missed the $2.42 billion estimate by a wider margin.

Headline revenue growth of 10.8% year over year looks healthy, but it flatters the underlying business. The acquired Leggett & Platt operations contributed $372.6 million during their partial-quarter period. GAAP results were weaker. EPS fell 10.8% to $0.74 from $0.83, net income declined 7.8% to $163.5 million, and gross margin narrowed to 42.0% from 44.9%. The most damaging piece was guidance. Management lowered its 2026 adjusted EPS range to $2.85–$2.95 from $2.85–$3.15, and the new $2.90 midpoint sits well below the $3.10 analysts had been modeling.

Management attributed much of the shortfall to the rollout of a new ERP system at Dreams, its U.K. retail chain. The rollout disrupted deliveries after July 1, and Dreams sales fell 34.7%. The company estimates the disruption cost roughly $50 million in sales and $25 million in adjusted EBITDA. Management also cited softer bedding demand and higher transport costs. It expects the global bedding market to contract by a mid-single-digit percentage in the second half, a sobering outlook for a company whose growth depends on consumers replacing big-ticket household goods.

Analysts responded quickly. On November 10, Morgan Stanley cut its price target to $90 from $95 while keeping an Overweight rating. The broader market added pressure. October CPI rose 0.4% against a 0.3% expectation, and the S&P 500 fell about 0.7% while the Nasdaq dropped 1.2% intraday. Rate-sensitive Consumer Discretionary names felt the inflation print as well. D.R. Horton, Inc. (DHI) fell 3.79% and PulteGroup, Inc. (PHM) dropped 3.89%. SGI's steeper decline, however, points to the earnings and guidance reset as the primary driver.


What is the Somnigroup International Inc. Rating - Should I Sell?

Weiss Ratings assigns SGI a C+ rating. Current recommendation is Hold. The C+ places Somnigroup at the upper end of the Hold range. That positioning reflects a business with real operating strengths whose shareholders have nonetheless endured a rough stretch, and this week's guidance cut makes it harder to argue the rating should move up soon.

The fundamental dimensions carry the rating. Somnigroup is rated Excellent on the Growth Index, which reflects how aggressively the company has expanded its footprint. Its acquisitions have created a vertically integrated bedding operation spanning manufacturing, components, and retail. The quarter's 10.8% revenue increase shows that scale building is still under way, even if much of it is acquired rather than organic. The Good rating on the Efficiency Index is supported by a 17.52% return on equity, a solid figure for a manufacturer absorbing integration costs. The 7.00% profit margin, however, shows how much of that revenue gets consumed before reaching the bottom line. The Good rating on the Solvency Index suggests the balance sheet can carry the acquisition burden. It does not rule out pressure if bedding demand keeps contracting into 2027.

The picture becomes more nuanced in the market-facing dimensions. Somnigroup is rated Fair on the Total Return Index, and a stock trading nearly 37% below its February peak has given back much of what shareholders gained earlier in the cycle. The Fair rating on the Dividend Index fits a 1.00% yield that offers little cushion against price declines. The Volatility Index is rated Weak. Tuesday's 5.84% single-session drop on an earnings miss and guidance cut is exactly the kind of sharp repricing that keeps that rating from moving higher. A forward P/E of 26.45 also leaves limited room for further execution stumbles.

Within the Consumer Discretionary sector, Somnigroup is on par with D.R. Horton, Inc. (DHI, C+) and sits above PulteGroup, Inc. (PHM, C). The gap widens against NVR, Inc. (NVR, C-) and Moncler S.p.A. (MONRF, C-), both of which carry less favorable risk/reward profiles in the Weiss framework. Somnigroup's relative standing is respectable, but it gives limited protection when the whole group is wrestling with inflation and softer consumer demand.


About Somnigroup International Inc.

Somnigroup International Inc. (SGI) is a Consumer Discretionary company headquartered in Lexington, Kentucky, and one of the world's largest bedding companies. It designs, manufactures, and markets mattresses, foundations, pillows, and related sleep products. Its portfolio includes Tempur-Pedic, known for proprietary memory-foam technology, along with Sealy and the premium Stearns & Foster line. Together these brands span price points from value to luxury.

The company's strategy has shifted sharply toward vertical integration. The acquisition of Mattress Firm gave Somnigroup direct control over one of the largest specialty mattress retail networks in the United States, adding to its existing retail presence. That presence already included Dreams in the United Kingdom and company-owned showrooms for its own brands. The more recent addition of Leggett & Platt extends that integration upstream into bedding components and related manufacturing. Somnigroup now participates in nearly every stage of the value chain, from springs and materials to the showroom floor.

The competitive case rests on brand recognition, manufacturing scale, and direct access to consumers. Owning both the leading brands and a large share of the retail shelf space lets Somnigroup shape the customer experience and capture margin that would otherwise go to third-party retailers. That model also concentrates exposure to discretionary spending on durable household goods. Integrating large acquisitions brings operational complexity of its own, as the Dreams ERP rollout demonstrated this quarter.


Investor Outlook

Somnigroup International Inc. (SGI) carries a Weiss Rating of C+ (Hold). The reduced 2026 guidance, an expected mid-single-digit contraction in the bedding market, and a stock already well off its highs argue for patience rather than bargain hunting. Investors should watch whether Dreams' delivery disruptions are resolved in the coming quarter, whether gross margin stabilizes above the 42.0% just reported, and whether the Leggett & Platt integration delivers organic growth rather than acquired revenue alone. See full rankings of all C+ rated Consumer Discretionary stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
AAPL NASDAQ $357.48
B
NVDA NASDAQ $162.11
B
MSFT NASDAQ $524.81
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $127.51
B
Top Financial Stocks
See All »
A
A
JPM NYSE $344.50
B
V NYSE $426.10
Top Energy Stocks
See All »
B
CVX NYSE $218.72
B
COP NYSE $142.17
Top Health Care Stocks
See All »
B
LLY NYSE $1,446.94
B
JNJ NYSE $286.73
B
ABBV NYSE $295.82
Top Real Estate Stocks
See All »
B
PLD NYSE $128.53
B
EQIX NASDAQ $1,055.08